Treatment with SRT1720, an SIRT1 activator, restored renal ATP levels through reduction of mitochondrial mass, nitrosative stress, and inflammation, leading to attenuation of I/R-induced kidney injury [11]. Here, SIRT1 is linked to kidney injury.